Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

Inclusion Criteria Patients must have: * Proof of HIV infection. * Diagnosis of asymptomatic HIV infection or early AIDS related complex (ARC) with no zidovudine (AZT) or other anti-HIV therapy. OR a diagnosis of AIDS and = or \> 3 months of AZT therapy. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: * HIV-induced neurological disease. * IgA negative. Concurrent Medication: Excluded: * Immunomodulating agents. * Steroids. * Interferons. Patients with the following are excluded: * Active substance abuse. * Use of immunomodulating drugs such as steroids or interferons. * HIV-induced neurological disease. * IgA negative. Required with a diagnosis of AIDS: * = or \> 3 months of zidovudine (AZT) therapy. Active substance abuse.